Activity not yet confirmed Verified 5 Nov 2026
Biomatics Capital
Seattle venture firm investing in data-enabled companies at the intersection of health care and technology, including genomics, therapeutics and diagnostics.
- Type
- VC firm
- Location
- Seattle, Washington, United States
- Stages
- Series B
- Backs
- Medtech and digital health, Biotech and pharma, Fintech
- Sectors
- Healthtech and life sciences, Biotech, Fintech
- Fund size / AUM
- $141.2M gross private fund assets (Form ADV; private funds: 1, of which venture capital: 1)
- Portfolio mix
- Medtech and digital health 58%; Biotech and pharma 25%; Fintech 17% (n=8)
- Website
- www.biomaticscapital.com
Contacts on file
For Biomatics Capital, the paid file holds: firm contact email (domain checked).
Get US Complete, $197 Free sample
One-time payment. No subscription. No account.
Notable investments
CompassAiCureAledadeCytrelliseGenesis
Sources
- adviserinfo.sec.gov/firm/summary/284637
- www.biomaticscapital.com/
- biomaticscapital.com/contact/
- biomaticscapital.com/portfolio/
Last checked 5 Nov 2026. Is something wrong? Tell us.
Appears in 20 lists
Series B biotech investors in the US (34)Series B medtech investors in the US (36)Series B medtech investors (57)Series B fintech investors in the US (59)Venture capital firms in Washington (69)Series B healthtech investors in the US (69)Series B biotech investors (73)Series B fintech investors (127)Series B healthtech investors (160)Series B investors in the US (165)Biotech venture capital firms in the US (297)Series B investors (339)Medtech venture capital firms in the US (350)Medtech investors (457)Biotech investors (484)Fintech venture capital firms in the US (525)Healthtech venture capital firms in the US (709)Fintech investors (846)Healthtech investors (1,207)Venture capital firms in the US (2,975)